Annual Long Term Debt
$59.46 M
+$1.05 M+1.80%
31 December 2023
Summary:
Taysha Gene Therapies annual long term debt is currently $59.46 million, with the most recent change of +$1.05 million (+1.80%) on 31 December 2023. During the last 3 years, it has risen by +$59.46 million (+100.00%). TSHA annual long term debt is now -5.76% below its all-time high of $63.09 million, reached on 31 December 2021.TSHA Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$60.72 M
+$4.75 M+8.49%
30 September 2024
Summary:
Taysha Gene Therapies quarterly long term debt is currently $60.72 million, with the most recent change of +$4.75 million (+8.49%) on 30 September 2024. Over the past year, it has increased by +$3.07 million (+5.33%). TSHA quarterly long term debt is now -4.03% below its all-time high of $63.27 million, reached on 30 September 2022.TSHA Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TSHA Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.8% | +5.3% |
| 3 y3 years | +100.0% | +11.6% |
| 5 y5 years | - | - |
TSHA Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -5.8% | -4.0% | +11.6% | |
| 5 y | 5 years | -5.8% | -4.0% | ||
| alltime | all time | -5.8% | -4.0% |
Taysha Gene Therapies Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $60.72 M(+8.5%) |
| June 2024 | - | $55.97 M(-5.2%) |
| Mar 2024 | - | $59.01 M(-0.8%) |
| Dec 2023 | $59.46 M(+1.8%) | $59.46 M(+3.1%) |
| Sept 2023 | - | $57.65 M(-0.4%) |
| June 2023 | - | $57.88 M(-0.4%) |
| Mar 2023 | - | $58.09 M(-0.5%) |
| Dec 2022 | $58.41 M | $58.41 M(-7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $63.27 M(+0.1%) |
| June 2022 | - | $63.19 M(+0.1%) |
| Mar 2022 | - | $63.14 M(+0.1%) |
| Dec 2021 | $63.09 M(>+9900.0%) | $63.09 M(+15.9%) |
| Sept 2021 | - | $54.42 M(+107.6%) |
| June 2021 | - | $26.21 M(>+9900.0%) |
| Dec 2020 | $0.00 | - |
| Dec 2020 | - | $0.00 |
FAQ
- What is Taysha Gene Therapies annual long term debt?
- What is the all time high annual long term debt for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual long term debt year-on-year change?
- What is Taysha Gene Therapies quarterly long term debt?
- What is the all time high quarterly long term debt for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly long term debt year-on-year change?
What is Taysha Gene Therapies annual long term debt?
The current annual long term debt of TSHA is $59.46 M
What is the all time high annual long term debt for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual long term debt is $63.09 M
What is Taysha Gene Therapies annual long term debt year-on-year change?
Over the past year, TSHA annual long term debt has changed by +$1.05 M (+1.80%)
What is Taysha Gene Therapies quarterly long term debt?
The current quarterly long term debt of TSHA is $60.72 M
What is the all time high quarterly long term debt for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly long term debt is $63.27 M
What is Taysha Gene Therapies quarterly long term debt year-on-year change?
Over the past year, TSHA quarterly long term debt has changed by +$3.07 M (+5.33%)